Press release
Tapentadol Market: Set for Rapid Growth and Trend by 2025
Request Report for TOC @ https://www.persistencemarketresearch.com/toc/20656
Tapentadol has been recognized as a step three analgesic on the World Health Organization (WHO) pain ladder. Tapentadol is utilized for the treatment of moderate to severe pain for chronic and acute musculoskeletal pain. Tapentadol is available in the U.S. in extended release formulations as Nucynta ER from Janssen Pharmaceuticals. Nucynta contains the (R,R) stereoisomer, which is a weak isomer in terms of opioid activity.
Tapentadol is often used to ease pain which cannot be managed with other types of analgesics. Tapentadol formulation is provided in 100 mg (red/orange), 75 mg (orange) and 50 mg (yellow) tablets to be used once every five hours as needed to control pain. In addition, tapentadol can be used for controlling the pain of diabetic neuropathy when round the clock analgesic is required.
Furthermore, tapentadol can be used to treat chronic depression, although it is not approved for this treatment. However, tapentadol is known to have adverse side effects. Tapentadol may impair cognitive and physical abilities and should not be used when operating heavy machinery, especially during initial treatment. Dizziness, nausea, constipation and central nervous system (CNS) sedation are common side effects of tapentadol. Tapentadol can increase the risk of seizure and should be administered carefully to epileptic patients.
The growth in the analgesic market is expected to increase the consumption of tapentadol. In addition, rising demand for over the counter painkillers in emerging economies of Asia Pacific is expected to boost demand for tapentadol. However, government regulations, availability of substitutes and adverse effects of tapentadol could hamper the growth of the market.The market is dominated by large pharmaceutical companies with established brands.
Request to Sample of Report- https://www.persistencemarketresearch.com/samples/20656
Some of the key players operating in this market are Johnson & Johnson Pharmaceutical Research & Development, L.L.C (U.S.), IPCA Laboratories Ltd (India), Lupin Laboratories Ltd (India), Ranbaxy Laboratories Ltd.(India), Aristo Pharmaceuticals Pvt Ltd (India), Cadila Pharmaceuticals Ltd (India), Tirupati Medicare Ltd (India) and Manus Aktteva Biopharma LLP (India) among others. Companies are investing in research and development to develop new grades of Tapentadol. In addition, companies are using strategic acquisitions and mergers to remain competitive in market and increasing their presence in emerging economies of Asia Pacific and Latin America.
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web:https://www.persistencemarketresearch.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Tapentadol Market: Set for Rapid Growth and Trend by 2025 here
News-ID: 940752 • Views: …
More Releases from Persistence Market Research
Active Modified Atmospheric Packaging Market to Surpass US$ 37.9 Bn by 2033, Dri …
The global active modified atmospheric packaging market is entering a dynamic growth phase as food manufacturers, healthcare suppliers, and logistics companies intensify their focus on extending product freshness, minimizing waste, and improving supply chain resilience. Active modified atmospheric packaging (AMAP) integrates advanced gas control technologies, moisture regulators, and antimicrobial features to create optimal internal environments for perishable products.
According to the latest study by Persistence Market Research, the global active modified…
Shunt Capacitor Market Expected to Reach US$2.0 Bn by 2033 Driven by Grid Modern …
The global shunt capacitor market is set for sustained growth as power grids worldwide undergo modernization to meet rising electricity demand and improve energy efficiency. According to the latest study by Persistence Market Research, the global shunt capacitor market size is likely to be valued at US$ 1.3 billion in 2026 and is projected to reach US$ 2.0 billion by 2033, expanding at a CAGR of 6% during the forecast…
Tire Cord & Tire Fabrics Market Set to Hit US$9.0 Bn by 2032 Driven by Radializa …
The global tire cord & tire fabrics market is entering a dynamic growth phase as automotive production rebounds, mobility patterns evolve, and manufacturers prioritize high-performance reinforcement materials. Tire cords and fabrics form the structural backbone of tires, providing dimensional stability, strength, and resistance to wear under demanding operating conditions.
According to the latest study by Persistence Market Research, the market is valued at US$5.9 billion in 2025 and is projected to…
Event Tourism Market Set for Exponential Growth through 2032 - PMR Research
The global Event Tourism Market is poised for remarkable expansion, driven by sustained demand for live experiences, increased business travel, hybrid event adoption, and a rebound in international tourism. According to industry projections, the market is expected to grow from an estimated US$1,538.3 billion in 2025 to US$2,631.5 billion by 2032, registering a CAGR of 7.3% over the forecast period.
This robust growth underscores the evolution of event tourism into one…
More Releases for Tapentadol
Tapentadol Market to Witness Huge Growth by 2031 - Johnson & Johnson Services, I …
DataM Intelligence has published a new research report on "Tapentadol Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/tapentadol-market
The…
The Tapentadol Market to witness an innovative overhaul between 2017 - 2025
Tapentadol Market
Tapentadol is an analgesic with a dual mode of action as a norepinephrine reuptake inhibitor and an agonist of the mu-opioid receptor. Its analgesic properties come into effect within few minutes of oral administration. Tapentadol is a new drug, being approved by the U.S. Food and Drug Administration (FDA) on the twenty sixth of August 2011, by the Therapeutic Goods Administration (TGA) of Australia on the twenty fourth of…
The next 10 years to see the Tapentadol Market making green strides
Tapentadol Market
Tapentadol is an analgesic with a dual mode of action as a norepinephrine reuptake inhibitor and an agonist of the mu-opioid receptor. Its analgesic properties come into effect within few minutes of oral administration. Tapentadol is a new drug, being approved by the U.S. Food and Drug Administration (FDA) on the twenty sixth of August 2011, by the Therapeutic Goods Administration (TGA) of Australia on the twenty fourth of…
Tapentadol Market Grows With Changing Consumer Preferences & New Opportunities
Market: Overview
Tapentadol is an analgesic with a dual mode of action as a norepinephrine reuptake inhibitor and an agonist of the mu-opioid receptor. Its analgesic properties come into effect within few minutes of oral administration. Tapentadol is a new drug, being approved by the U.S. Food and Drug Administration (FDA) on the twenty sixth of August 2011, by the Therapeutic Goods Administration (TGA) of Australia on the twenty fourth of…
Tapentadol Market High Growth Rate by 2025
Global Tapentadol Market: Snapshot
The growing prevalence of chronic diseases is leading to the high occurrence of chronic musculoskeletal pain, which is likely to create an upswing in the demand for tapentadol worldwide. Tapentadol is also used for the treatment of moderate to severe acute pain. The potency of this treatment lies somewhere between that of morphine and tramadol. Despite the lower occurrence of side effects, its analgesic efficacy is…
Middle East Tapentadol Market Forecast to 2025
Tapentadol is an opioid analgesic, indicated for severe pain management, on a daily or around the clock need for treatment and long-term opioid treatment, for which alternative treatment options are inadequate. Tapentadol is also indicated for neuropathic pain associated with diabetic peripheral neuropathy. It is widely used for management of acute, chronic, and cancer related pain among patients and is available legally on prescription. Nucynta ER is the first and…
